Weight LossPain Managementprinciples of treatmentdrug side effects
 

CURRICULUM VITAE

Name:

Dr Michael Lester Philip GROSS

Business Address:   

North of Thames:

105 Nibthwaite Road,
Harrow,
Middlesex,
HA1 1 TE

Tel: 0208  861  1777
Fax: 0208  863  7124

South of Thames:

Gatwick Park Hospital,
Povey Cross Road
Horley, Surrey
RH6 0BB

Tel: 01293  771132
Fax: 01293  771131

Place of Birth:

Hertfordshire, England

Nationality:

English

GMC

2310709

Defence Organisation:

Medical Protection Society

Education:

  • 1963 - 1970 - Minchenden School, Southgate

  • 1970 - 1973 - Sydney Sussex College, Cambridge

  • 1973 - 1976 - The Royal London Hospital Medical School

Degrees:

  • 1973 - BA (Hons) (Cambridge) Medical Sciences

  • 1976 - MB, BChir (Hons) (Cambridge)

  • 1976 - MA (Cambridge)

  • 1978 - MRCP (UK)

  • 1987 - MD (Cambridge)

  • 1995 - FRCP (UK)

  • 1998 - Founder Member Expert Witness Institute (MEWI)

Accreditation:

Accredited in neurology and neurophysiology by the Royal College of Physicians 

Appraisal:

Full appraisal by consultant under jurisdiction of Clementine Churchill Hospital, 2004 - 2010

Recent Awards:

  • 1998, shortlisted Multiple Sclerosis Society Measuring Success Awards, four categories

  • 1998 and 1999, Leader of Neurology Team shortlisted for Neurology Team of the Year, United Kingdom

  • 1998 and 1999, Shortlisted Hospital Doctor of the Year, Distinctions: United Kingdom

  • 1992  -  Fellowship Award. Glaxo 

  • 1980, Action Research Training Fellowship to undertake Doctorate

Current Position:

  • Consultant Neurologist and Clinical Director of Neurophysiology at the Clementine Churchill Hospital, Sudbury Hill, Harrow, Middlesex HA1 3RX

  • Consultant Neurologist and Director of Neurophysiology at Gatwick Park Hospital, Povey Cross Road, Horley, Surrey RH6 0BB

  • Neurology Adviser to Watford Football Club

Medico-legal Experience:

  • Preparation of medico-legal reports since 1982

  • At present, 150 – 300 new instructions each year. 

  • Numerous appearances in Court (3-5/year). 

  • Regular conferences with Counsel.

  • Current instructions equally split between Claimant, Defendant and joint instruction.

  • Work involved in personal injury and medical negligence.  Also DDA, Testamentary Capacity, Employment Tribunal

  • Invited lecturer to Personal Injury Barristers Association Annual

  • Meeting 2005 entitled “Makers, Takers and Fakers” and similar

  • Lecture to APIL 2006 and Association of British Neurosurgeons 2007

  • Numerous lectures to Societies, Legal Forums and Chambers on a range of neurological topics

Medico-legal Specialist areas:

  • Brain injury, spinal injury, headache, blackouts and funny turns, epilepsy, dizziness, multiple sclerosis and neuropathy, general clinical neurology.

  • Founder member Expert Witness Institute

  • Expert Witness Panel of the Law Society (“Checked Witness”)

Membership of
Professional
Organisations:  

  • Fellowship of the Royal College of Physicians

  • Fellowship of the Royal Society of Medicine

  • Association of British Neurologists

  • World Federation of Neurology

  • International Headache Society

  • European Federation of Neurological Societies

  • Member of Expert Witness Institute

Membership of advisory bodies:

  • Previous Chairman, Division of Neurological Sciences, Royal Surrey

  • County Hospital, Guildford

  • Previous Chairman, South West Surrey Stroke Advisory Committee

  • Previous Chairman, East Surrey Stroke Advisory Committee

  • Member, Medical Advisory Committee, Gatwick Park Hospital (2004-2008)

  • Chairman Neurosciences User Group, Clementine Churchill Hospital, Harrow

  • Chairman Neurosciences User Group, Gatwick Park Hospital

  • Numerous Advisory Committees in relation to research in headache,epilepsy, multiple sclerosis and chronic fatigue

  • Previous Member of the Medical Advisory Committee of the Migraine Trust.

  • Member of the International Headache Society

  • Member of the World Federation of Neurologists

  • Member of the European Federation of Neurological Science

Previous appointments:

  • February 1990 – June 2001 – Consultant Neurologist at the Royal Surrey County Hospital in Guildford

  • Consultant Neurologist and Director of Neurophysiology to the East Surrey Group of Hospitals, Redhill, Surrey RH1 5RH.

  • During the tenure of this post, Chairman of Neurosciences at the Royal Surrey County Hospital  1991 – 2001

  • 1986 – 1990 – Senior Registrar at the National Hospital For Neurology and Neurosurgery, Queen Square, London WC1 and St Marys Hospital, Paddington, London WC2.
    During the tenure of this post, eighteen months Locum Consultant position between a Hertfordshire Group of Hospitals and the Royal Free Hospital in Hampstead.

  • 1983 – 1986 – Resident (Registrar) and Senior Resident at the National Hospital, Queen Square and Maida Vale. 

  • 1982 – 1983 – Registrar in Neurology, The Royal Free Hospital, Hampstead.

  • 1981 – 1982 – Research Registrar at the Royal Free Hospital undertaking Doctorate project.

  • 1980 – Renal Registrar, The Royal Free Hospital

  • 1979 – Senior House Officer and Registrar, Hammersmith Hospital

  • 1978 – Senior House Officer in Neurology, The National Hospital for Neurology and Neurosurgery.

  • 1977 – Senior House Officer posts in General Medicine and Cardiology at the North Middlesex Hospital and the London Chest Hospital

  • 1976/1977 – House Physician and House Surgical posts at the Royal London Hospital

Media background:

Numerous articles and appearances in relation to health care, headache/analgesic overuse and its under-provision.

Invited lectures:

I have given more than a hundred invited lectures over the years to local, national and international groups on a number of neurological topics.  I have been the organiser of numerous Neurology Study Conferences and acted as Chairman of those meetings as well as chaired numerous sessions within significant scientic meetings.

In recent years, I have been asked to lecture to the Harveian Society, the Medico-Legal Society and the Association of Personal Injury Barristers (APIB).  I have also lectured at the Royal Society of Medicine on several occasions.

Personal Statement: 

During my eleven years as a Consultant Neurologist at The Royal Surrey County Hospital, I was elected Chairman of the Neuroscience Department and held that position for ten years.  I left the NHS in June 2001. I had stated publicly that it was unsafe to practice neurology within the NHS in Surrey and Sussex. 

I continue to have a large clinical private practice (20 – 30 new patient referrals each week).  I have in-patient beds at the Clementine Churchill Hospital and Gatwick Park Hospital. 

Approximately 20% of my clinical time is spent in the undertaking of medico-legal work

I employ five people in my practice with two full-time offices in Harrow and Gatwick.  My team ensure a rapid response to any correspondence or telephone contact.

I am part of a Neurosciences Peer Supervision Group who meet regularly and discuss mutual matters.  We are currently undertaking      a research project on “The Validation of Symptoms” to be published shortly.

I am currently writing a book on “Abuse and Abusive Behaviour”.

PUBLICATIONS

  1. BRETTLE  R P, GROSS  M L P,  LEGG  N J, LOCKWOOD  M C, PALLIS  C
    Treatment of acute polyneuropathy by plasma exchange.  Lancet 11, 1100, 1978

  2. LEGG  N J, GROSS  M L P, BOULOUX  P M
    Extent of cuts in computerised tomography of the brain.  Lancet 1, 1299, 1979, Letter

  3. GROSS  M L P, BOULOUX  P M, LEGG  N J
    Parasaggital meningioma presenting as low grade glioma on computerised tomographic scan.
    Lancet 1, 821, 1979 (letter)

  4. GROSS  M L P, TEOH  R, LEGG  N J, PALLIS  C
    Ocular myopathy and Marfan’s syndrome: a family study.  Journal of the Neurological Sciences.  46, 1, 105-112. 1980

  5. GROSS  M L P. 
    Acute dystonia as an idiosyncratic reaction to Haloperidol.  Lancet 11, 479-480.
    1980 (letter)

  6. SWENY P, HOPPER  J, GROSS  M L P, VARGHESE  Z
    Nephrotoxicity of cyclosporine A.  Lancet 1, 663, 1981 (letter)

  7. SWENY  P, WINNING  A, GROSS  M L P, MOORHEAD  J F             
    Plasmapheresis in the haemoloytic uraemic syndrome in children.  British Medical Journal 1981.

  8. GROSS  M L P, BAILLOD  R,  PEARSON  R M, SWENY  P
    Plasma exchange and haemodialysis as a combined procedure.  Plasma Therapy, 2, 4. 255. 1981

  9. GROSS  M L P, SWENY  P, LEGG  N J
    Successful plasmapheresis in the Miller-Fisher syndrome.  British Medical Journal 1. 282. 1981 (letter)

  10. GROSS  M L P, PEARSON  R M, SWENY  P, FERNANDO  O, MOORHEAD  J F
    Rejection encephalopathy.  EDTA Proceedings, 18, 461-464. 1981

  11. GROSS  M L P, THOMAS  P K
    The treatment of chronic progressive and chronic relapsing polyneuropathy by plasma exchange.  Journal of Neurological Science.  52, 69-78, 1981

  12. GROSS  M L P, LEGG  N J, LOCKWOOD  M, PALLIS  C
    The treatment of inflammatory polyneuropathy by plasma exchange.  Journal of Neurology, Neurosurgery & Psychiatry, 45, 675-679, 1982

  13. GROSS  M L P, PEARSON  R M, SWENY  P, KENNEDY  J, FERNANDO O, MOORHEAD  J F
    Rejection encephalopathy; an acute neurological syndrome complicating renal transplantation. Journal of Neurological Sciences 56, 23-34, 1982

  14. GROSS  M L P, PEARSON  R M, KENNEDY  J, MOORHEAD  J F, SWENY  P.
    Rejection encephalopathy.  Lancet ii, 1217, 1982 (letter)

  15. GROSS  M L P
    The treatment of acute polyneuropathy by plasma exchange.  Journal of Neurology, Neurosurgery & Psychiatry.  46, 267, 1983

  16. GROSS  M L P, CRAGGS  R, KING  R H M, THOMAS  P K
    The modification of experimental allergic neuritis with plasma exchange.  Journal of Neurological Sciences, 61, 149-160, 1983

  17. KING  R H M, CRAGGS  R, GROSS  M L P, TOMPKINS  C, THOMAS  P K
    The suppression of experimental allergic neuritis by cyclosporine.  Acta Neuropathologica (Berlin) 59, 262-8, 1983

  18. MILLAR  A, CLARKE  S W, DAVIS  S N, GROSS  M L P
    Prolonged ventilation in severe asthma caused by the Guillain-Barre-Strohl syndrome.
    Journal of the Royal Society of Medicine, 77, 965-66, 1984

  19. GROSS  M L P, CRAGGS  R
    A method of plasma exchange in an experimental auto-immune disease.  Apheresis 2, 1, 7-12, 1984

  20. GROSS  M L P
    The treatment of inflammatory polyneuropathy with plasma exchange.  Apheresis 2, 1, 7-12, 1984

  21. GROSS  M L P, PEARSON  R M, SWENY  P, MOORHEAD  J F
    Convulsions associated with cyclosporin A in renal transplant recipients. British Medical Journal 290, 555, 1985 (letter)

  22. CRAGGS  R, GROSS  M L P, KING  R H M, THOMAS  P K
    Effects of glucocorticoids on experimental allergic neuritis.  Experimental Neurology 87, 9-19, 1985

  23. GROSS  M L P
    Giant middle cerebral aneurysm presenting with unilateral Parkinsonism.  Journal of Neurology, Neurosurgery & Psychiatry, 50, 1075, 1987

  24. KREEGER  L, GROSS  M L P, NIEMAN  E
    MRI scanning in case of HTLV-3 associated tropical spastic paraparesis.  Journal of Neurology, Neurosurgery & Psychiatry, 1988

  25. GROSS  M L P,  HO  R, FOWLER  C, HARRISON  M J, RUSSELL  C
    Polyneuropathy complicating severe pancreatic disease.  Journal of Neurology, Neurosurgery & Psychiatry

  26. GROSS  M L P
    The therapeutic modification of inflammatory polyneuropathy.  M D Thesis, University of Cambridge 1987

  27. BROWN  S, GROSS  M L P, HARRISON  M J
    Paraplegia following oral hypotensive treatment of malignant hypertension.  Journal of Neurology, Neurosurgery & Psychiatry, 50, 104, 1987

  28. GROSS  M L P
    A case of chronic relapsing inflammatory polyneuropathy complicating Sjorgens syndrome.  Journal of Neurology, Neurosurgery & Psychiatry, 50, 939, 1987

  29. GINSBERG  L, GROSS  M L P, CLLIFFORD JONES  R, MORGAN HUGHES  J
    A case of chronic hypothermia, relapsing extrapyramidal syndrome and marrow aplasia.
    Journal of Neurology, Neurosurgery & Psychiatry

  30. VAN DE POEL  H, GROSS  M L P
    Pink visioin – report of four cases

  31. KENNEDY  A, GROSS  M L P
    The sphenoid sinus revisited – a report of two cases.  Paper completed

  32. GROSS  M L P, MUTHTHUSWAMY  S, EARL  C J
    The clinical syndrome of spinal cord compression by tumour – 92 cases reviewed

  33. LLEWELYN  G,  BRADLEY  C, GROSS  M L P
    Acute aphasia as the presenting feature in a case with HIV infection, 1989

  34. GROSS  M L P, KAY  J, TURNER  A M, HALLETT  K, CLEAL  A L, HASSANI  N
    Sumatriptan in acute migraine using a novel cartridge system self-injector.  Headache 1994:
    34: 559-563

  35. GROSS  M L P, KAY  J, TURNER  A M, JEWSBURY  J, CLEAL  A L
    Long-term efficacy of subcutaneous Sumatriptan using a novel self-injector.  Headache 1995:
    35: 601-606

  36. GROSS  M L P
    The use of Sumatriptan in the treatment of migraine.  British Journal of Clinical Practice 1993:
    47, 4 205-7

  37. STEINER  T J, DELLAPORTAS  C I, JESTICO  J, FINDLEY  L J, GROSS  M L P et al
    Lamotrigine monotherapy in newly diagnosed untreated epilepsy; A double-blind comparison with Phenytoin.  Epilepsy 1996

  38. CULL  R E, GROSS  M L P, DOWSON  A, PRICE  W H, BATES  D, GIBSON  J
    Evaluation of a new migraine diagnostic questionnaire.  Cephalalgia 1996

  39. GROSS  M L P
    Pizotifen in hemifacial spasm.  Journal of Neurology, Neurosurgery & Psychiatry 1996

  40. GROSS  M L P
    Current and future therapies for migraine.  Exp Opin Invest Drugs 1995, 4 (4): 283-290

  41. LIPTON  E B, AMATNIEK  J, FERRARI  M D, GROSS  M L P
    Migraine: Identifying and removing barriers to care.  Neurology 1994, 4 (Suppl 4): 563-68

  42. GROSS  M L P et al
    Migraine Management Guidelines.  Synergy 1993

  43. GROSS  M L P
    Stroke: The intrusive platelet, 1993, 5: 1-3

  44. GROSS  M L P, DOWSON  A, DEAVEY  L, DUTHIE  T
    Impact of oral Sumatriptan 50 mg. on work productivity quality of life.  British Journal of Medical Economics, 1996 (In Press)

  45. MAIN  A, DOWSON  A, GROSS  M L P
    Photophobia and phonophobia in migraineurs between attacks.  Headache 1997 37, 8, 492-496

  46. CULL  R E, GROSS  M L P, DOWSON  A, PRICE  W H, BATES  D, GIBSON  J
    Evaluation of a new diagnostic questionnaire.  Headache 1997

  47. GROSS  M L P, BARRIE  M, BATES  D, DOWSON  A, ELRINGTON  E
    The efficacy of oral Sumatriptan in menstrual migraine – a prospective study.
    Cephalalgia 1998

  48. TEALL  J, TUCKMAN  M, CUTLER  N, GROSS  M L P et al
    Rizatriptan (Maxalt) for the acute treatment of migraine and migraine recurrence.
    A placebo controlled out-patient study.  Headache 1998, 38: 281-287

  49. STEINER  T J, DELLAPORTAS  C I, FINDLEY  L J, GROSS  M L P et al
    Lamotrigine monotherapy in newly diagnosed untreated epilepsy.  A double-blind comparison with Phenytoin.  Epilepsia 1999

  50. Vigabatrin European Monotherapy Study Group
    A multi-centre randomised double-blind study comparing the safety and efficacy of Vigabatrin and Carbamazepine in newly diagnosed epilepsy.  Epilepsia 1999

  51. BRODIE  M et al
    A multi-centre double-blind randomised comparison trial of Lamotrigine and Carbamazepine in elderly patients with newly diagnosed epilepsy.  The Lancet 1999

PRESENTATIONS AT MEETINGS AND  ABSTRACTS

  1. GROSS  M L P, LEGG  N J
    The treatment of chronic relapsing polyneuropathy by plasma exchange
    Meeting of the Royal Society of Medicine, 1979

  2. GROSS  M L P, THOMAS  P K
    The treatment of chronic progressive and chronic relapsing polyneuropathy by plasma exchange.  Association of British Neurologists meeting York, 1981

  3. GROSS  M L P, PEARSON  R  M, SWENY  P, MOOREHEAD  J M
    Rejection encephalopathy.  European dialysis and transplant association meeting, Paris 1981

  4. GROSS  M L P, THOMAS  P K
    The treatment of experimental allergic neuritis by plasma exchange.  Association of British Neurologists meeting, Brighton 1982

  5. GROSS  M L P, THOMAS  P K
    The treatment of experimental allergic neuritis by cyclosporin A.  First International Congress of Neuroimmunology, Strese 1981

  6. GROSS  M L P, CRAGGS  R
    The treatment of experimental allergic neuritis by plasma exchange.  4th International Congress of Neuromuscular Diseases, Marseilles 1982

  7. GROSS  M L P, THOMAS  P
    Chronic polyneuropathies treated with plasma exchange.  European Society for Clinical Investigation, Travemunde 1983

  8. GROSS  M L P
    Controlled trial of plasma exchange in experimental allergic neuritis.  European Society for Clinical Investigation, Travemunde 1983

  9. GROSS  M L P
    Is demyelinating neuropathy a treatable disease?  Queen Square Research Society, February 1984

  10. GROSS  M L P, GAUTIER  SMITH  P
    The anatomical basis of hemidystonia..  Meeting of the Royal Society of Medicine (neurology section). December 1985

  11. GROSS  M L P
    The role of plasma exchange in chronic relapsing and chronic progressive polyneuropathy.
    Sixth International Congress of Neuromuscular Diseases, Los Angeles 1986

  12. GROSS  M L P, GAUTIER SMITH  P
    A case of Wegener’s disease.  Meeting of the Royal Society of Medicine (neurology section) 1987

  13. GROSS  M L P
    The treatment of chronic relapsing inflammatory polyneuropathy by plasma exchange
    Association of British Neurologists Meeting, London 1987

  14. GROSS  M L P, MUTHTHUSWAMY  C, EARL  C J
    The clinical syndrome of spinal cord compression by tumour.  Queen Square Research Society, 1988

  15. GROSS  M L P, MUTHTHUSWAMY  C, EARL  C J
    The clinical syndrome of spinal cord compression by tumour.  European Neurological Society, Nice 1988

  16. GROSS  M L P, MUTHTHUSWAMY  C, EARL  C J
    The clinical syndrome of spinal cord compression by tumour.  Association of British Neurologists Meeting, Hammersmith 1988

  17. GROSS  M L P
    Spinal cord compression S.E.N.A. 1992

  18. GROSS  M L P
    Representing Sumatriptan auto-injector study group.  Sumatriptan is effective in acute migraine by new auto-injector device.  Migraine Trust 1994

  19. MAIN  A, DOWSON  A, GROSS  M L P
    A case controlled study of photophobia and phonophobia in migraine patients between attacks.
    Cephalalgia 1995, 15 (14) 284.  7th International Headache Congress, Toronto 1995

  20. DOWSON  A, STEVENS  C, SENDER  J, GROSS  M L P
    The Royal and East Surrey Neurology Research Unit.  Does establishment of a Migraine Research Unit alter clinical referral patterns?  Cephalalgia 1995, 15 (14) 42.  7th International Headache Congress, Toronto 1995

  21. STEVENS  C, DOWSON  A, GROSS  M L P
    The Royal and East Surrey Neurology Research Unit.  A retrospective study of migraine patients participating in drug research programmes.  Cephalalgia 15 (14) 281.  7th International Headache Congress, Toronto 1995

  22. GROSS  M L P, BARRIE  M, BATES  D, DOWSON  A, ELRINGTON  E
    The efficacy of oral Sumatriptan in menstrual migraine – a prospective study.  Cephalalgia 1995, 15 (14) 227.  7th International Headache Congress, Toronto 1995

  23. CULL  R, GROSS  M L P, DOWSON A, PRICE  W, BATES  D
    An investigation into the validation of a new migraine diagnostic questionnaire.  Cephalalgia 1995, 15 (14) 27.  7th International Headache Congress, Toronto 1995

  24. GRUFFYDD-JONES  K, HOOD  C, PRICE  D, DOWSON  A
    Patient preference for subcutaneous and oral Sumatriptan in acute treatment of migraine.
    Cephalalgia 1995  15 (14) 173,  7th International Headache Congress, Toronto 1995

  25. DOWSON  A, RAMPHUL-GOKULSING  S, KLEIN  K, COX  R, WILKINSON  M, GROSS  M L P
    Can oral 311C90 , a novel 5HT1D agonist prevent migrainous headache when taken in aura?
    Cephalalgia 1995 15 (14) 173.  7th International Headache Congress, Toronto 1995

  26. DOWSON  A, RAMPHUL-GOKULSING  S, KLEIN  K, COX  R, WILKINSON  M, GROSS  M L P
    A pilot study to investigate whether Zolmitriptan (311C90), a novel 5HT1D agonist can be used as acute prophylaxis to prevent a migraine headache.  6th International Headache Research Seminar, Copenhagen 1995

  27. FLETCHER  P, LOWY  M T
    On behalf of the 311C90 long term study group.  Evaluation of the long term safety and efficacy of Zolmitriptan (311C90) in the treatment of migraine.  6th International Headache Research Seminar, Copenhagen 1995

  28. ROTHWELL K, DOWSON  A
    Patient evaluation of acute migraine treatments.  6th International Headache Research Seminar, Copenhagen 1995

  29. CULL  R, GROSS  M L P, DOWSON  A, PRICE  W, BATES  D, GIBSON  J
    An investigation into the validation of a new migraine diagnostic questionnaire.  European Federation of Neurological Science, Marseilles 1995

  30. DOWSON  A, GROSS  M L P  et al
    The efficacy of oral Sumatriptan in menstrual migraine – a prospective study.  European
    Federation of Neurological Science, Marseilles 1995

  31. DOWSON  A, GROSS  M L P
    The value of Sumatriptan as an acute treatment for migraine. European Federation of Neurological Science, Marseilles 1995

  32. DOWSON  A, GROSS  M L P
    The value of Sumatriptan as an acute treatment for migraine.  3rd European Headache Federation, Sardinia 1996

  33. DIENER  H C, KLEIN  K B, GROSS  M L P
    For the Multinational Oral 311C90 and Sumatriptan comparative study group.  The first comparison of the efficacy and safety of 311C90 and Sulmatriptan in the treatment of migraine.  3rd European Headache Federation, Sardinia 1996.  Functional Neurology (1996) (11) 2/3, 153

  34. FLETCHER  P E, McDONALD  S, LOWY  M T, GROSS  M L P
    For the Multinational 311C90 long term study group.  Long term safety and efficacy and pattern of usage of 311C90 in the acute oral treatment of migraine.  3rd European Headache Federation, Sardinia 1996

  35. RYAN jnr  R E, ELKIND  A H, GOLDSTEIN  J, GROSS  M L P
    For CN115-020 BMS study group.  24 hour response rate and incidence of recurrence of BMS 180048 in the acute treatment of migraine headaches.  3rd European Headache Federation, Sardinia 1996.  Functional Neurology (1996) (11) 2/3, 148

  36. HANSEN  P, FLETCHER  P E, LOWY  M T, GROSS  M L P
    On behalf of the international 311C90 long term study group.  Evaluation of the long term safety and efficacy of 311 C90 in the treatment of migraine.  3rd European Headache Federation, Sardinia 1996

  37. DOWSON  A, GROSS  M L P, MATTHEW  N T, COUCH  J
    Functional improvement and patient acceptability of BMS 180048 in the treatment of patients with acute migraine.  3rd European Headache Federation, Sardinia 1996.  Functional Neurology (1996) (11) 2/3, 147. 

  38. RYAN jnr  R E, ELKIND  A, GOLDSTEIN  J, MONDELL  B, MATTHEW  B, COUCH jnr  J, KUDROW  D, DUBOFF  E, THEIN jnr  S, BROWN  W, LEGG  N, GROSS  M L P
    Twenty-four hour effectiveness of BMS 180048 in the acute treatment of migraine.  Functional Neurology (1996) (11) 2/3, 148.  3rd European Headache Federation, Sardinia 1996

  39. ELKIND  A H, GOLDSTEIN  J, RYAN jnr  R E, GROSS  M L P
    For the CN 115-020 study group.  Use of a test dose for determining safety of a 5HT1 like agonist BMS 180048 in 216 subjects.  European Headache Federation, Sardinia 1996
    Functional Neurology (1996) (11) 2/3, 147

  40. GOLDSTEIN  J,  RYAN  R E, ELKIND  A H, GROSS  M L P
    For the CN 115-020 BMS Study group.  A double blind trial of BMS 180048 at 75 mg,         150 mg. and 200 mg. in the acute treatment of migraine headaches.  European Headache Federation, Sardinia 1996.  Functional Neurology (1996) (11) 2/3, 147

  41. DOWSON  A, GROSS  M L P, DEAVEY  L, DUTHIE  T
    An assessment of the economic and quality of life impact of oral Sumatriptan (50 mg).
    European Journal of Neurology Vol. 3 Supplement 5, p 148.  European Federation of Neurological Science, Rome 1996

  42. LOWY  M T, KYNOCH  D, HOWARD  D, FLETCHER  P E, GROSS  M L P
    On behalf of the International 311C90 long term study group.  An interim analysis of the long term safety, efficacy and pattern of usage of 311C90 in the acute oral treatment of migraine.
    America Academy of Neurology, April 1996

  43. DOWSON  A  (GROSS  M L P)
    An open dose titration study evaluating 25 mg, 50 mg. and 100 mg. doses of oral Sumatriptan in the acute treatment of migraine.  Cephalalgia 17 (3) 419  8th International Headache Congress, Amsterdam 1997

  44. DOWSON  A (GROSS  M L P)
    An open dose titration study of three doses of Sumatriptan tablets in the acute treatment of migraine over a six month period.  American Association for the Study of Headache.
    New York 1997

  45. DOWSON  A,  (GROSS  M L P)
    An open dose titration study of 25 mg. 50 mg. and 100 mg. doses of oral Sumatriptan in the acute treatment of migraine.  JNSCAG 150 (Suppl) S170, 3-21-15

  46. TUCHMAN  M M, DOWSON  A, MILLSON  D S, FLETCHER  P E (GROSS  M L P)
    Maximising migraine relief with Zolmitriptan: Star final data from an open label study with   > 49,000 treated attacks.  50th American Acadamy of Neurology, Minneapolis 25 April - 2 May 1998

  47. MAIN  A, DOWSON  A  (GROSS  M L P)
    Report of the effect of wave length on photophobia in headache-free migraineurs.
    XII Migraine Trust, London Sept 1998

  48. GROSS  M L P
    “Who goes there?  The medical profession, government and judiciary – friends or foe?
    Journal of the Medico-legal Society.  2008